Special Announcement - Now Enrolling for FDA Approved Stem Cell StudyDr. Mitchell Sheinkop has completed training and is credentialed for the first of its kind FDA approved stem cell clinical trial for knee arthritis. Our clinic is now enrolling patients in this trial. Contact us at 312-475-1893 for details. Click here to learn more.

On Social Distancing and the Developing Stem Cell Trials for COVID-19 Patients

Mar 30, 2020

Every July 4th through Labor Day, from 1945 until 1954, my family would pack up the car and head off to spend the summer in Glenn, Michigan, several blocks from the lake. We lived in Humboldt Park on Division Street in Chicago. It was a third floor, one-bedroom apartment with a den. Air conditioning was not yet readily available.My brother and I shared the pull-out couch in the den. My father would drive out past the Gary Works Steel mills to Glenn each Friday night and return home on Sunday night so he wouldn’t miss work. He was a self-employed cabinet maker, having learned both his trade and the English language after fleeing Poland before WW2. He would take his yearly two-week vacation and spend it in the rented “cottage” ($50 for six weeks) equipped with an outhouse and a real ice box. The ice man came with a block twice a week. As there were no interstate highways or toll roads at the time, the drive would take 3 to 4 hours each way.

Social Distancing to Prevent the Spread of Illness

In medical school while studying infectious disease, I learned that the Summer 1952 Polio Epidemic had afflicted 57,628 Americans resulting in 3,145 deaths. It was only then when I realized the reason behind our yearly migration for Social Distancing. My family was avoiding the overcrowding that resulted in the spread of Polio, although, until Salk and Sabin, no one knew how. As an Orthopedic Surgeon at Children’s Memorial Hospital between 1974 to 1983, there were still several iron lungs in use to support children with respiratory distress, of varying causation, for prolonged periods. In the present COVID-19 Pandemic, the means of disease transfer is well understood. What remains to be done is the development of a treatment and a vaccination rendering immunity.

I share the following document from The Personalized Stem Cell group with whom I am an investigator for arthritis. I thought you would appreciate the government and White House briefings (two calls already with VP Task Force):

We are manufacturing large quantities of allogeneic donor MSCs for treatment of COVID-19 patients

Have approval of IRB for protocol

Filing with FDA next week for emergency IND

Attached draft of protocol justification manuscript

“Situation • The government has asked private biopharmaceutical companies to step up • Many Americans will die or have long term disability from COVID-19 • Critical we find treatments to keep people off ventilators and reduce mortality • PSC has 17 years of stem cell experience and has deployable resources to treat COVID-19 patients, but needs capital and fast track regulatory access

Why Stem Cell Therapy for COVID-19*

How patients die

Massive inflammation by the body’s over-reaction to the viral invasion

Lung inflammation prevents oxygen getting to the bloodstream

Many patients will die even if a ventilator is available

Stem cell therapy – Scientific published evidence*

Reduce lung damage and inflammation

Improve oxygen supply to the body

Repair damaged lung and prevent scar tissue

Produce natural antibiotics and antivirals

Clear edema and fluid from the lung

How Effective – Scientific Published Evidence*

Reduce death loss by 50%-90%

Reduce days in the ICU

Reduce need for ventilator

Clinical data that stem cells work against COVID-19 and other viral diseases

Over 20 clinical studies started in China in just the last 60 days with early published striking results

How Safe – Scientific Published Evidence*

Thousands of patients safely treated with stem cells in hundreds of clinical trials for a variety of diseases with very limited side effects